| Prostate Cancer - Clinical and Scientific Aspects: Bridging the Gap Contributor(s): Abel, Paul David (Editor), Lalani, El-Nasir (Editor) |
|
 |
ISBN: 1860943276 ISBN-13: 9781860943270 Publisher: Imperial College Press OUR PRICE: $429.40 Product Type: Hardcover Published: December 2003 Annotation: Despite the advent of the genomic era, the perceived benefits of close collaboration between clinicians and scientists are not always realised and the gap between bench and bedside remains. Closer collaboration should expedite advances in treating disease. This important book, with a foreword by Fritz H Schroder, is designed to enhance the relationship between the two communities. It contains data from a multinational authorship, the forty chapters being written by experts with widely differing training and expectations. Their aim is to facilitate both understanding and in-depth knowledge of their subject. By bridging the gap between clinicians and scientists, the hope is to enhance translational research in their common goal of improving the diagnosis and treatment of prostate cancer, the single most important cancer affecting men. |
| Additional Information |
| BISAC Categories: - Medical | Oncology - General - Medical | Urology |
| Dewey: 616.994 |
| Physical Information: 2.13" H x 6.34" W x 9.22" (4.32 lbs) 1256 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: Despite the advent of the genomic era, the perceived benefits of close collaboration between clinicians and scientists are not always realised and the gap between bench and bedside remains. Closer collaboration should expedite advances in treating disease. This important book, with a foreword by Fritz H Schr der, is designed to enhance the relationship between the two communities. It contains data from a multinational authorship, the thirty-eight chapters being written by experts with widely differing training and expectations. Their aim is to facilitate both understanding and in-depth knowledge of their subject. By bridging the gap between clinicians and scientists, the hope is to enhance translational research in their common goal of improving the diagnosis and treatment of prostate cancer, the single most important cancer affecting men. |